New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

FHLCvsFXHETF Comparison

ETF 1
FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of
US Health Care
+0.44%
VS
ETF 2
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+0.44%

Fidelity MSCI Health Care Index ETF (FHLC) and First Trust Health Care AlphaDEX Fund ETF (FXH) belong to the same industry segment: US Health Care. FHLC's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, FXH's top sector exposures are Healthcare. FHLC is less expensive with a Total Expense Ratio (TER) of 0.084%, versus 0.61% for FXH. FHLC is up 17.08% year-to-date (YTD) with +$482M in YTD flows. FXH performs better with 19.23% YTD performance, and +$33M in YTD flows. Run a side-by-side ETF comparison of FHLC and FXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FHLC vs FXH performance and flow charts

Performance

-2.00.02.04.0%Sep 28Oct 5Oct 12Oct 19Oct 26

Cumulative Flows

-40 M-20 M0 M20 M40 M60 M80 MSep 28Oct 5Oct 12Oct 19Oct 26

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/27/2026
1M3MYTD1Y3Y5Y
Perf.
FHLC
FXH
+3.89%+2.43%
+8.96%+8.19%
+17.08%+19.23%
+23.78%+19.78%
+56.26%+52.55%
+41.35%+16.55%
Flows
FHLC
FXH
+$81M-$39M
+$230M+$39M
+$482M+$33M
+$546M+$39M
-$171M-$459M
+$19M-$464M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FHLC
FXH
+16.90%+15.19%
+15.87%+15.66%
+14.89%+15.64%
+15.50%+16.95%
Max drawdown
FHLC
FXH
-5.64%-4.82%
-10.35%-12.07%
-16.88%-17.66%
-17.78%-27.47%
Max drawdown duration
FHLC
FXH
56d55d
169d168d
435d395d
762d1638d
Trading data

Create an account to view trading data

Join for free
FHLC
FXH
Last sale
10/28/2026 at 1:30 PM
$86.60
$136.04
Previous close
10/27/2026
$86.08
$134.95
Consolidated volume
10/27/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FHLC
FXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/28/2026 at 1:30 PM
Live
Closed
FHLC
FXH
Last price
$86.60
$136.04
1D performance
+0.60%
+0.81%
AuM$3.83 B$1.14 B
E/R0.084%0.61%
Characteristics
FHLC
FXH
Management strategyPassivePassive
ProviderFidelityFirst Trust
BenchmarkMSCI USA IMI Health Care 25/50 IndexStrataQuant Health Care Index
N° of holdings33872
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateOctober 21, 2013May 8, 2007
ESGNoNo
Advertisement
Exposure

Countries

FHLC
USA
97.14%
Other
2.86%
FXH
USA
93.13%
Other
6.87%

Sectors

FHLC
Healthcare
98.23%
Other
1.77%
FXH
Healthcare
98.23%
Other
1.77%
Advertisement

Diversification

FHLC

Total weight of top 15 holdings out of 15

60.85%
FXH

Total weight of top 15 holdings out of 15

35.47%

Top 15 holdings

Data as of August 31, 2026
FHLC
Eli Lilly & Co.
12.94%
Johnson & Johnson
8.88%
AbbVie, Inc.
6.21%
Merck & Co., Inc.
5.04%
UnitedHealth Group, Inc.
4.91%
Amgen, Inc.
3.21%
Thermo Fisher Scientific, Inc.
3.19%
Abbott Laboratories
2.69%
Gilead Sciences, Inc.
2.49%
Pfizer Inc.
2.19%
Vertex Pharmaceuticals, Inc.
1.90%
Danaher Corp.
1.89%
Bristol Myers Squibb Co.
1.87%
Intuitive Surgical, Inc.
1.82%
CVS Health Corp.
1.63%
FXH
Regeneron Pharmaceuticals, Inc.
2.86%
Pfizer Inc.
2.56%
Natera, Inc.
2.55%
Solventum Corp.
2.55%
Zimmer Biomet Holdings, Inc.
2.49%
Universal Health Services, Inc.
2.48%
Boston Scientific Corp.
2.43%
Guardant Health, Inc.
2.37%
Tenet Healthcare Corp.
2.29%
Halozyme Therapeutics, Inc.
2.22%
The Cigna Group
2.22%
Centene Corp.
2.20%
Globus Medical, Inc.
2.20%
Corcept Therapeutics, Inc.
2.10%
Encompass Health Corp.
1.95%
Frequently asked questions about FHLC and FXH

How have the FHLC and FXH ETFs performed in 2026?

As of October 27, 2026, FHLC is up 17.08% year-to-date (YTD), while FXH has returned 19.23%. That puts FXH better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or FXH?

Year-to-date, the FHLC ETF saw +$482M in flows, compared to +$33M for FXH.

Which ETF is more volatile: FHLC or FXH?

Over the past year, FHLC had a volatility of 15.87%, while FXH experienced 15.66%.

Which ETF is bigger: FHLC or FXH?

As of October 27, 2026, FHLC holds $3.83 B in assets under management (AUM), while FXH manages $1.14 B.

What sectors do the FHLC and FXH ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, FXH focuses on Healthcare.

What are the top holdings of the FHLC ETF and FXH ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FXH holds in its top three: Regeneron Pharmaceuticals, Inc., Pfizer Inc. and Natera, Inc..

Which ETF is more diversified: FHLC or FXH?

FHLC holds 338 securities with 60.85% of its assets in the top 15. FXH has 72 securities and a top 15 weight of 35.47%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026